Navigation Links
Angioplasty The Much Preferred Treatment Of Choice For Heart Attacks

A new study finds angioplasty should be the treatment of choice for heart attack patients, even if the hospital they initially go to doesn’t offer angioplasty// services and they have to be transferred to another facility for treatment.

Research has shown heart attack patients fare better when they are treated with angioplasty to open up the clogged blood vessel that caused the attack than when they are treated with a clot-busting drug therapy called fibrinolysis.

Danish researchers involved around 1,500 heart attack patients in their study from 24 hospitals without angioplasty services and five hospitals with such services. Patients at the 24 hospitals were randomly assigned to either treatment with fibrinolysis at the facility where they were first admitted or treatment with angioplasty at another hospital that offered the service, if they could be transferred to the new hospital within two hours.

Researchers analyzed results, looking at a combination of death, clinical evidence of another heart attack (reinfarction), or a disabling stroke within 30 days. Results showed patients who received angioplasty were significantly more likely to survive, regardless of whether they had been transferred to another hospital to receive the angioplasty or not. Overall, only 8.5 percent of the angioplasty group suffered a complication, compared to 14.2 percent of those in the fibrinolysis group. The primary benefit was a reduction in the rate of reinfarction among the angioplasty patients. Little difference was noted between the groups in death or stroke rates.
'"/>




Page: 1

Related medicine news :

1. Cholesterol Drug Helps After Angioplasty
2. Angioplasty Should be the Standard
3. The Success Rate Of Angioplasty In Female Patients Low
4. Angioplasty death risk reduced by doubling drug dose
5. Angioplasty death risk reduced by doubling drug dose
6. A ray of hope in Angioplasty dilemma
7. Angioplasty plus stenting better than thrombolysis for elderly patients with AMI
8. Patients Fare Better With Doctors Who Do More Angioplasty Procedures
9. Researchers Begin Study To Find Out If Angioplasty Can Be Safely Done In Smaller Hospitals
10. Drug-Coated Stents Work Better In Diabetic Patients After Angioplasty
11. Togadiyas Condition Stable After Undergoing Angioplasty
Post Your Comments:
(Date:12/5/2009)... NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative ... Research presented today at the 51st Annual Meeting ... new treatment options and improved diagnostic methods for ... leukemia, infant acute lymphoblastic leukemia, and myelofibrosis that ...
(Date:12/5/2009)... Solutions, an innovative new international private medical insurance plan which follows ... offering customers the flexibility to add or remove a wide range ... customers to tailor their benefits to complement those already offered in ... ...
(Date:12/4/2009)... Care Investment Trust Inc. (NYSE: CRE ) ("Care" ... declared a dividend of $0.17 per share of common stock. ... of record on December 14, 2009. ,, ... a real estate investment and finance company investing in healthcare-related real ...
(Date:12/4/2009)... and Services for the Aging (AAHSA) applauds the Senate for ... provisions remain in the final health reform legislation . The ... with disabilities and their caregivers. ,, We urge the ... make it affordable to care for families and caregivers. , ...
(Date:12/4/2009)... 4 Pamela Bowen, Chief Information Officer at Crescent ... Innovation Officer" Appy Award for transforming Crescent,s business with ... nominated based on their innovative usage of Salesforce CRM ... customer success to their sales, marketing, partner, service, support ...
Breaking Medicine News(10 mins):Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2
... PHILADELPHIA, Oct. 1 The national law ... announced that it is forming a,Professional Liability practice ... Hoffman including name partner Peter Hoffman. The group ... Eckert Seamans, Philadelphia,and Harrisburg offices and create a ...
... 1 AnnTaylor Stores Corporation,(NYSE: ANN ), a ... be,stepping up its support of women around the world ... sale of its ANN Cares,Card in- store and on-line. ... 30, 2007 through,October 31, 2007 and will entitle cardholders ...
... IN COMMUNICATIONS, COORDINATION, ... DEATHS, LOSSES, RICHMOND, Va., Oct. 1 In the ... the U.S., a,repeat of 2005,s medical catastrophes and loss of ... Global Secure, a leading provider,of emergency preparedness and response systems ...
... BOSTON, Oct. 1 The Regulatory Affairs,Professionals ... the,global healthcare products regulatory profession, announced at ... of "Regulatory Affairs Professional,Development Framework: An Overview," ... and abilities of regulatory professionals. The ...
... Architect to Build on Foundation,s Momentum In Pursuing ... ... The Michael J. Fox,Foundation for Parkinson,s Research (MJFF) today announced ... been,appointed Interim Chief Executive Officer. Ms. Hood, who joined the,Foundation in ...
... Educational ... Resource at IDSA Annual Meeting, HADDON HEIGHTS, N.J., Oct. ... continuing education,resource as part of their exhibit booth at the ... October 4-7, in San Diego,California. Project CDAD: Outbreak Prevention and ...
Other Medicine News:Health News:Eckert Seamans Announces Major Expansion in Philadelphia, West Chester and Harrisburg 2Health News:Eckert Seamans Announces Major Expansion in Philadelphia, West Chester and Harrisburg 3Health News:Ann Taylor Launches ANN Cares Card to Support Fight Against Breast Cancer 2Health News:Natural Disaster Rescue Teams at Public Health Facilities Across the Country Learn from Katrina Failures 2Health News:Natural Disaster Rescue Teams at Public Health Facilities Across the Country Learn from Katrina Failures 3Health News:New RAPS White Paper Details Career Development of Healthcare Products Regulatory Professionals 2Health News:New RAPS White Paper Details Career Development of Healthcare Products Regulatory Professionals 3Health News:Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation 2Health News:National Experts Team Up to Help Hospitals Prevent and Control C. difficile Outbreaks 2
(Date:12/4/2009)... Drs. Neal Shore and E. David Crawford presented ... analysis of secondary end points of biochemical recurrence rate ... degarelix for injection) or monthly leuprolide in prostate cancer ... cancer patients who received FIRMAGON 240/80 mg/month had a ...
(Date:12/4/2009)... Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity ... among the comorbidities reported to occur more often ... with epilepsy versus those without an epilepsy diagnosis, ... across the U.S. ,, Findings from " CNS-Related ...
(Date:12/3/2009)... and STATE COLLEGE, Pa., Dec. 3 Ambry ... an agreement to provide extended bioinformatics genomics services ... performed at Ambry. ,, (Logo: ... CSO said, "Our team at Ambry has been ...
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3New DNA and RNA aptamers offer unique therapeutic advantages 9488 1New DNA and RNA aptamers offer unique therapeutic advantages 9488 21957 58 Flu Pandemic Can Provide Clues to Planning for h1n1 53765 11957 58 Flu Pandemic Can Provide Clues to Planning for h1n1 53765 2Recondo Technology Introduces New Software Service for Hospitals 53761 1Recondo Technology Introduces New Software Service for Hospitals 53761 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: